780 results
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 24-27 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/10/2022 to 27/10/2022, Last updated: 04/07/2022 -
List item
Paediatric Committee (PDCO): 21-24 June 2022
Virtual meeting, from 21/06/2022 to 24/06/2022, Last updated: 21/06/2022 -
List item
Paediatric Committee (PDCO): 19-22 April 2022
Virtual meeting, from 19/04/2022 to 22/04/2022, Last updated: 16/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 07/06/2022 -
List item
Paediatric Committee (PDCO): 22-25 March 2022
Virtual meeting, from 22/03/2022 to 25/03/2022, Last updated: 03/06/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 28-30 March 2022
from 28/03/2022 to 30/03/2022, Last updated: 19/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Paediatric Committee (PDCO): 22-25 February 2022
Virtual meeting, from 22/02/2022 to 25/02/2022, Last updated: 06/05/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 24-26 January 2022
from 24/01/2022 to 26/01/2022, Last updated: 06/05/2022 -
List item
Paediatric Committee (PDCO): 12-15 October 2021
Virtual meeting, from 12/10/2021 to 15/10/2021, Last updated: 11/03/2022 -
List item
Paediatric Committee (PDCO): 20-23 July 2021
Virtual meeting, from 20/07/2021 to 23/07/2021, Last updated: 21/02/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 20-22 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 20/09/2021 to 22/09/2021, Last updated: 07/12/2021 -
List item
Committee for Herbal Medicinal Products (HMPC): 22-24 November 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/11/2021 to 24/11/2021, Last updated: 07/12/2021 -
List item
News: Call for expressions of interest for civil society representatives to participate in work of EMA
PRAC, Last updated: 27/10/2021 -
List item
Committee for Herbal Medicinal Products (HMPC): 5-7 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 07/07/2021, Last updated: 01/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
Paediatric Committee (PDCO): 7-10 September 2021
Online, from 07/09/2021 to 10/09/2021, Last updated: 09/09/2021 -
List item
Paediatric Committee (PDCO): 20-23 April 2021
Virtual meeting, from 20/04/2021 to 23/04/2021, Last updated: 30/06/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2021 to 10/06/2021, Last updated: 07/06/2021 -
List item
Paediatric Committee (PDCO): 23-26 March 2021
Virtual meeting, from 23/03/2021 to 26/03/2021, Last updated: 12/05/2021 -
List item
Press briefing on the conclusion of the investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events by the Pharmacovigilance Risk Assessment Committee (PRAC)
Virtual meeting, 18/03/2021, Last updated: 19/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021